Inosine Monophosphate Dehydrogenase
肌苷单磷酸脱氢酶
基本信息
- 批准号:6720721
- 负责人:
- 金额:$ 25.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Inosine monophosphate dehydrogenase (IMPDH) enzyme catalyzes the rate-limiting step in guanine nucleotide biosynthesis: the conversion of inosine monophosphate (IMP) to xanthosine monophosphate (XMP) with concomitant reduction of NAD. IMPDH controls the size of the guanine nucleotide pool, which in turn controls proliferation and many other important cellular processes. IMPDH inhibitors are antiproliferative, making the enzyme a drug target for virtually every disease; specific IMPDH inhibitors could be used as immunosuppressive, cancer, antiviral or antimicrobial chemotherapy. We have shown that IMPDH undergoes a large conformational change in mid-catalytic cycle that converts the enzyme from a dehydrogenase to a hydrolase, and thus presents a unique opportunity to investigate the role of conformational dynamics in catalysis. This conformational change also appears to be a major determinant of drug selectivity. This proposal outlines an investigation of the mechanism and function of IMPDH. We will delineate the structural features that account for the varied activities of IMPDH isozymes. In addition to being crucial for the design of isozyme-specific inhibitors of IMPDH, this work will be an important contribution to understanding the relationship between structure and function in enzyme catalysis.
描述(由申请人提供):肌苷单磷酸脱氢酶(IMPDH)催化鸟嘌呤核苷酸生物合成中的限速步骤:肌苷单磷酸(IMP)转化为黄苷单磷酸(XMP),伴随NAD还原。IMPDH控制鸟嘌呤核苷酸库的大小,这反过来又控制增殖和许多其他重要的细胞过程。IMPDH抑制剂具有抗增殖作用,使该酶成为几乎所有疾病的药物靶标;特异性IMPDH抑制剂可用作免疫抑制剂、癌症、抗病毒或抗微生物化疗。我们已经表明,IMPDH经历了一个大的构象变化中的催化循环,将酶从脱氢酶的水解酶,从而提出了一个独特的机会,调查构象动力学在催化中的作用。这种构象变化似乎也是药物选择性的主要决定因素。该提案概述了对人权事务国际法庭的机制和职能的调查。我们将描绘的结构特征,占不同的活动IMPDH同工酶。除了对IMPDH同工酶特异性抑制剂的设计至关重要之外,这项工作还将对理解酶催化中结构与功能之间的关系做出重要贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lizbeth K. Hedstrom其他文献
Lizbeth K. Hedstrom的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lizbeth K. Hedstrom', 18)}}的其他基金
2022 & 2024 Drug Resistance Gordon Research Conference and Seminar
2022年
- 批准号:
10468465 - 财政年份:2022
- 资助金额:
$ 25.56万 - 项目类别:
Ubiquitin-independent targeted protein degradation
不依赖泛素的靶向蛋白质降解
- 批准号:
10678852 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Ubiquitin-independent targeted protein degradation
不依赖泛素的靶向蛋白质降解
- 批准号:
10240677 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Ubiquitin-independent targeted protein degradation
不依赖泛素的靶向蛋白质降解
- 批准号:
10797292 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Ubiquitin-independent targeted protein degradation
不依赖泛素的靶向蛋白质降解
- 批准号:
10810215 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Ubiquitin-independent targeted protein degradation
不依赖泛素的靶向蛋白质降解
- 批准号:
10021774 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Inhibition of mTOR by a small molecule activator of TSC2
TSC2 小分子激活剂对 mTOR 的抑制
- 批准号:
9976416 - 财政年份:2019
- 资助金额:
$ 25.56万 - 项目类别:
相似海外基金
Development of alcohol dehydrogenase (ADH) and ene-reductase (ERED) enzymes for the production of enantiopure sulphur-containing flavours and fragranc
开发乙醇脱氢酶 (ADH) 和烯还原酶 (ERED),用于生产对映体纯含硫香料和香料
- 批准号:
2406555 - 财政年份:2020
- 资助金额:
$ 25.56万 - 项目类别:
Studentship
Alcohol dehydrogenase in alcohol-related organ disorder
酒精脱氢酶在酒精相关器官疾病中的作用
- 批准号:
19H04038 - 财政年份:2019
- 资助金额:
$ 25.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Enzymatic and metabolic adaptation to chronic alcohol consumption mediated by alcohol dehydrogenase 1 and 3 in mice.
小鼠中乙醇脱氢酶 1 和 3 介导的对慢性饮酒的酶促和代谢适应。
- 批准号:
16K09223 - 财政年份:2016
- 资助金额:
$ 25.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DISSERTATION RESEARCH: Alcohol dehydrogenase in Drosophila: Functional characterization of adaptive genetic variation
论文研究:果蝇中的乙醇脱氢酶:适应性遗传变异的功能特征
- 批准号:
1501877 - 财政年份:2015
- 资助金额:
$ 25.56万 - 项目类别:
Standard Grant
A comprehensive analysis of the role of the Alcohol Dehydrogenase gene cluster in alcohol-related disorders and esophageal cancer through deep resequencing
通过深度重测序全面分析酒精脱氢酶基因簇在酒精相关疾病和食管癌中的作用
- 批准号:
nhmrc : 1060663 - 财政年份:2014
- 资助金额:
$ 25.56万 - 项目类别:
Project Grants
Pilot testing of a novel alcohol dehydrogenase enzyme isolated from thermococcus guaymasensis
从圭马热球菌中分离出的新型乙醇脱氢酶的中试
- 批准号:
411606-2010 - 财政年份:2010
- 资助金额:
$ 25.56万 - 项目类别:
Engage Grants Program
Structure and function of membrane-bound quinohemoprotein Alcohol dehydrogenase
膜结合醌血红素蛋白乙醇脱氢酶的结构和功能
- 批准号:
19570110 - 财政年份:2007
- 资助金额:
$ 25.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Control of substrate specificity of alcohol dehydrogenase by pressurizing
通过加压控制乙醇脱氢酶的底物特异性
- 批准号:
19550168 - 财政年份:2007
- 资助金额:
$ 25.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
STRUCTURAL STUDY OF ARABIDOPSIS CAD5 (CINNAMYL ALCOHOL DEHYDROGENASE 5) ENZYME
拟南芥CAD5(肉桂醇脱氢酶5)酶的结构研究
- 批准号:
7598075 - 财政年份:2007
- 资助金额:
$ 25.56万 - 项目类别:
Novel alcohol dehydrogenase catalyzed oxidation and reduction in supercritical carbon dioxide
新型醇脱氢酶催化超临界二氧化碳氧化和还原
- 批准号:
19685007 - 财政年份:2007
- 资助金额:
$ 25.56万 - 项目类别:
Grant-in-Aid for Young Scientists (A)














{{item.name}}会员




